Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.
Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?
By the time the second hand on your wristwatch has circled its dial, a child in Africa will have died of malaria.
For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.
GSK is working together with Save the Children and the Department of Foreign Affairs and Trade in Australia, to support the establishment of a new Emergency Health Unit EHU which can respond to natural disasters such as hurricanes and earthquakes, and provide essential healthcare during slow-acting disasters like malnutrition.
GSK expands graduated approach to patents and intellectual property to widen access to medicines in the world’s poorest countries.
A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries